Valuation Highnoon Laboratories Limited

Stocks

End-of-day quote Pakistan S.E. Other stock markets 24/06/2026			5-day change	1st Jan Change
997.93 ^PKR	+2.31%		+1.96%	-2.40%

05-19	Highnoon Laboratories Appoints Dr. Shahzad Khan as Managing Director of Highnoon Life Sciences	CI
04-30	Highnoon Laboratories Limited Approves Final Cash Dividend for the Year Ended December 31, 2025	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2024	2025	2026	2027	2028
Market Cap ¹	48,650	54,175	52,874	-	-
Change	-	11.36%	-2.4%	-	-
Enterprise Value (EV)	48,650	54,175	52,874	52,874	52,874
Change	-	11.36%	-2.4%	0%	0%
P/E	14.4x	-	-	-	-
PBR	-	-	-	-	-
PEG	-	-	-	-	-
Capitalization / Revenue	-	1.96x	1.74x	1.55x	1.38x
EV / Revenue	-	0x	1.74x	1.55x	1.38x
EV / EBITDA	-	-	-	-	-
EV / EBIT	-	-	-	-	-
EV / FCF	-	-	-	-	-
FCF Yield	-	-	-	-	-
Dividend per Share ²	-	50	45	52	60
Rate of return	-	4.89%	4.51%	5.21%	6.01%
EPS ²	63.95	-	-	-	-
Distribution rate	-	-	-	-	-
Net sales ¹	-	27,706	30,398	34,163	38,399
EBITDA	-	-	-	-	-
EBIT	-	-	-	-	-
Net income	3,389	-	-	-	-
Net Debt	-	-	-	-	-
Reference price ²	918.22	1,022.49	997.93	997.93	997.93
Nbr of stocks (in thousands)	52,983	52,983	52,983	-	-
Announcement Date	3/26/25 A	4/7/26 A	-	-	-

¹PKR in Million²PKR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
HIGHNOON LABORATORIES LIMITED	-	-	-	4.51%	190M
ELI LILLY AND COMPANY	32.86x	12x	24.39x	0.61%	1,006B
JOHNSON & JOHNSON	26.17x	6.03x	16.39x	2.18%	589B
ABBVIE INC.	30.87x	7.21x	14.74x	2.85%	430B
ROCHE HOLDING AG	17.87x	4.45x	10.93x	2.99%	331B
ASTRAZENECA PLC	23.29x	4.86x	13.76x	1.8%	288B
NOVARTIS AG	21.56x	5.56x	13.49x	2.84%	285B
NOVO NORDISK A/S	13.98x	5.17x	10.65x	3.6%	213B
AMGEN INC.	22.94x	6.13x	10.71x	2.86%	190B
GILEAD SCIENCES, INC.	-44.37x	5.36x	29.56x	2.62%	154B
Average	16.13x	6.31x	16.07x	2.68%	348.6B
Weighted average by Cap.	23.24x	7.53x	17.44x	2.05%